Presenting Author: Sharon CM Essink, MSc (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
### she/her/hers @@@ Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. ### 1659068###Author###Senior Pharmacovigilance assessor###Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.###Author: Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
### @@@ Sabine MJM Straus, MD, PhD – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands. ### 1094834###Author###Chair of PRAC, associate professor###Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.###Author: Sabine MJM Straus, MD, PhD – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
### @@@ Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University ### 1061395###Author###Associate professor###Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University###Author: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
### @@@ Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1360157###Author###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Author: Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hers OP4-3Presenting Author: Emeline Maisonneuve, MD (she/her/hers) – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
### she/her/hers @@@ Eva Gerbier – Pharmacy department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland ### 1359620###Author###PhD student###Pharmacy department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland###Author: Eva Gerbier – Pharmacy department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
### @@@ Fatima Tauqeer – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, , Oslo, Norway ### 1063106###Author###PhD student###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, , Oslo, Norway###Author: Fatima Tauqeer – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, , Oslo, Norway
### @@@ Léo Pomar, PhD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland ### 1659156###Author###Midwife and Professor###Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland###Author: Léo Pomar, PhD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
### @@@ Guillaume Favre, MD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland ### 1659150###Author###PhD student###Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland###Author: Guillaume Favre, MD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
### @@@ Ursula Winterfeld, PhD – Pharmacy department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland ### 1359633###Author###Pharmacist###Pharmacy department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland###Author: Ursula Winterfeld, PhD – Pharmacy department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
### @@@ Anneke Passier, PhD – Teratology Information Service, Pharmacovigilance Centre Lareb, ‘s Hertogenbosch, The Netherlands ### 1900305###Author###Teratology information specialist###Teratology Information Service, Pharmacovigilance Centre Lareb, ‘s Hertogenbosch, The Netherlands###Author: Anneke Passier, PhD – Teratology Information Service, Pharmacovigilance Centre Lareb, ‘s Hertogenbosch, The Netherlands
### @@@ Alison Oliver, PhD – UKTIS, Newcastle upon Tyne Hospitals, NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tynes, UK ### 1900306###Author###Senior Medical Information Scientist###UKTIS, Newcastle upon Tyne Hospitals, NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tynes, UK###Author: Alison Oliver, PhD – UKTIS, Newcastle upon Tyne Hospitals, NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tynes, UK
### @@@ David Baud, MD PhD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child department, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland ### 1359631###Author###Head of department###Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child department, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland###Author: David Baud, MD PhD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child department, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
### @@@ Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1358057###Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Michael Ceulemans, PhD – Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium ### 1900303###Author###Pharmacist and researcher###Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium###Author: Michael Ceulemans, PhD – Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
### @@@ Alice Panchaud, PhD – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland ### 1900290###Author###Head of BIHAM Pharmacy###Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland###Author: Alice Panchaud, PhD – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
### OP1-3Presenting Author: Kamika Reynolds, PhD – Sanofi
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
### OP3-2Presenting Author: Anna-Belle Beau, PhD – Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, Toulouse, France
### @@@ Xavier Moisset – Université Clermont Auvergne, CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Clermont-Ferrand ### 1900353###Author###Medical Doctor###Université Clermont Auvergne, CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Clermont-Ferrand###Author: Xavier Moisset – Université Clermont Auvergne, CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Clermont-Ferrand
### @@@ Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1900337###Author###Researcher###PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Author: Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Marie Beslay, PhD – Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, France. ### 1900336###Author###Postdoctoral researcher###Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, France.###Author: Marie Beslay, PhD – Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, France.
### @@@ Claudia C. Bartolini – ARS Toscana ### 1063227###Author###Researcher###ARS Toscana###Author: Claudia C. Bartolini – ARS Toscana
### @@@ Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France ### 1658844###Author###Statistician###Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France###Author: Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki ### 1360036###Author###Professor###Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki###Author: Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki
### @@@ Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea ### 1359730###Author###professor###Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea###Author: Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea
### @@@ Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France ### 1358268###Author###Head of Statistics and Data management###Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France###Author: Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
### @@@ Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1358190###Author###Associate professor###Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Author###Associate Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Author: Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University, Italy ### 1900338###Author###Specialist in health statistics and biometrics###Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University, Italy###Author: Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University, Italy
### @@@ Visa Martikainen – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1359729###Author###Data manager, statistician###Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###Author: Visa Martikainen – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Joan K. Morris – St George's, University of London, London ### 1900343###Author###Professor###St George's, University of London, London###Author: Joan K. Morris – St George's, University of London, London
### @@@ Amanda j. Neville, N/A – Registro IMER University of Ferrara and Azienda Ospedaliero Universitario S Anna, Ferrara, Italy ### 1359720###Author###Registry Leader, IMER Registry###Registro IMER University of Ferrara and Azienda Ospedaliero Universitario S Anna, Ferrara, Italy###Author: Amanda j. Neville, N/A – Registro IMER University of Ferrara and Azienda Ospedaliero Universitario S Anna, Ferrara, Italy
### @@@ Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1358057###Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy ### 1359270###Author###Researcher###Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy###Author: Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy
### @@@ Jingping Mo – Worldwide Medical and Safety, Pfizer Inc., New York, NY ### 1358153###Author###Professor###Worldwide Medical and Safety, Pfizer Inc., New York, NY###Author: Jingping Mo – Worldwide Medical and Safety, Pfizer Inc., New York, NY
### @@@ Christine Damase-Michel, PhD, PharmD – Université Toulouse III ### 1358255###Author###Associate Professor in Pharmacology###Université Toulouse III###Author: Christine Damase-Michel, PhD, PharmD – Université Toulouse III
### OP1-4